We are live on ! Find out more
NWBOW

Northwest Biotherapeutics, Inc.
NWBOW

Delisted

NWBOW was delisted on the 16th of December, 2016.

Back to rankings

4 hedge funds and large institutions have $302K invested in Northwest Biotherapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding

Funds holding: 1 → 4 (+3)

68% more capital invested

Capital invested by funds: $180K → $302K (+$122K)

Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SHGA
Sand Hill Global Advisors
California
+$33.4K
2
AIG
American International Group
New York
+$17.4K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
1
Allianz Asset Management
Germany
$249K – – –
SHGA
2
Sand Hill Global Advisors
California
$35K +$33.4K +12,500 New
AIG
3
American International Group
New York
$18K +$17.4K +6,500 New
MAM
4
Majedie Asset Management
United Kingdom
– +$276K +103,380 New

NWBOW Hedge Fund Activity: Q4 2013 in Review

4 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. (NWBOW) for Q4 2013, worth a combined $302K — up 68% from $180K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NWBOW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sand Hill Global Advisors, opening a new position worth an estimated $33.4K.

  • 4 institutional investors held Northwest Biotherapeutics, Inc. (NWBOW) as of Q4 2013, up from 1 in Q3 2013.
  • Funds reported $302K of Northwest Biotherapeutics, Inc. stock for Q4 2013, up 68% quarter-over-quarter.
  • 3 funds opened new Northwest Biotherapeutics, Inc. positions in Q4 2013 and 0 closed out, a net change of +3 holders.
  • The largest Northwest Biotherapeutics, Inc. buyer in Q4 2013 was Sand Hill Global Advisors, an estimated $33.4K added.

Based on aggregated 13F filings for Q4 2013.